\
&
Contact us
\
&
Contact us
This was 9 months ago
LocationBrussels
ProgrammesJoin two back-to-back events aiming to bring together healthcare provides and SMEs to address challenges and opportunities in health data innovation and digital health solutions. Day 1 dives into leveraging health data within healthcare organisations, while Day 2 emphasises scaling and co-creating digital health solutions with SMEs.
Day 1 - Workshop for Healthcare providers only
Explore opportunities and challenges in leveraging health data while gaining insights into key European initiatives like the European Health Data Space (EHDS) and AI Act. Join healthcare professionals from across Europe to share experiences and best practices.
When? 4 March (13:00 - 19:00 incl. networking reception); Where? EIT House, Rue Guimard 7, 1040 Brussels
Day 2 - Catalyst event for SMEs
Discover hospital needs, pitch your solutions, and explore funding opportunities under the European Partnership for Personalised Medicine (EP PerMed) and services under TEF-Health, the testing & experimentation facility for Health AI and Robotics. Collaborate with healthcare leaders to scale digital health innovations and accelerate their impact.
When? 5 March (10:00 - 14:00 incl lunch); Where? Herman Teirlinck, Havenlaan 88, 1000 Brussels
More information and registration on the event website: Driving Innovation in Health Data and Digital Health.
The event is co-organised by Medvia, VITO, AGORIA, TEF-Health, TRAIL, lifetech.brussels, AI4Belgium, BioWin, CETIC, Multitel & EIT Health Belgium-Netherlands.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
